PREX1 and prostate carcinoma: Among the pro-metastatic Rac-GEFs, Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) has been found to be highly expressed in many types of tumors, including melanoma, breast, prostate cancer and others [17].